PA3-17 Injection in Adult Patients With CD7-positive Relapsed/Refractory T-lymphoblastic Leukemia/Lymphoma | ClinicalTrials HQ

Ask about research services

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
PA3-17 Injection in Adult Patients With CD7-positive Relapsed/Refractory T-lymphoblastic Leukemia/Lymphoma	CD7-positive Relapsed/Refractory T Lymphoblastic Leukemia/Lymphoma	Recruiting	Phase 2	2026-07-06		NCT07188610

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
PersonGen BioTherapeutics (Suzhou) Co., Ltd.	13

16 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
Facility Name: Guangdong Provincial People's Hospital	Guangzhou	China	1
Henan Cancer Hospital	Zhengzhou	China	76
Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences	Tianjin	China	3
Jiangsu Province Hospital	Nanjing	China	14
Peking University People's Hospital	Beijing	China	12
Peking University Third Hospital	Beijing	China	21
Sun Yat-sen University Cancer Center (SYSUCC)	Guangzhou	China	2
The Affiliated Hospital of Xuzhou Medical University	Xuzhou	China	30
The First Affiliated Hospital of Soochow University	Suzhou	China	36
The First Affiliated Hospital of University of Science and Technology of China (Anhui Provincial Hospital)	Hefei	China	1
The First Affiliated Hospital of Zhengzhou University	Zhengzhou	China	125
The First Affiliated Hospital, Zhejiang University School of Medicine	Hangzhou	China	39
The First Hospital of Harbin	Harbin	China	1
Tongji Hospital, Tongji University	Shanghai	China	1
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology	Wuhan	China	37
West China Hospital, Sichuan University (WCHSU)	Chengdu	China	1